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The complete sequence of several genomes is now avail-
able, and we have ready access not only to the sequence of
virtually every individual gene sequence of interest but also
to a global overview of an entire genome at once. Studies
and approaches that comprehensively and simultaneously
address the entire genome were termed ‘‘genomics’’. New-
er fields have arisen from genomics. For example, the global
study of all transcribed genes in a given cell type under
given conditions, i.e., of the ‘‘transcriptomes’’, are called
‘‘transcriptomics’’ or ‘‘functional genomics’’; the global
study of all proteins found in a cell, of the ‘‘proteome’’, are
‘‘proteomics’’; and even further afield we find ‘‘glycomics’’,
‘‘lipomics’’, ‘‘pharmacogenomics’’, etc.1 Still new, these re-
search areas have matured enough to have their own lan-
guage, methodology, and even a dedicated journal,
‘‘OMICS, A Journal of Integrative Biology’’ (Kolker, 2002).
The ‘‘omics’’ studies are characterized by massive
amounts of data. These require bioinformatics, the special-
ized computer-based analytical approaches that include
large databases and various analysis tools (Della Vedova
and Dondi, 2003). The data analysis algorithms are usually
custom-designed for a specific application and have be-
come a wholly new field of creative research that bridges,
sometimes uneasily, biology and computer sciences. Omics
often integrate distinct and diverse disciplines that were in-
dependent in the past. The common goal of the ‘‘omics’’
approach is termed ‘‘systems biology’’, because it encom-
passes a broad and comprehensive view of its topic, an
integrated biological ‘‘system’’.
Genomic studies in humans nowadays often focus on the
mapping of genes responsible for human diseases or traits,
including difficult multi-locus or quantitative differences be-
tween individuals. A large collection of polymorphic DNA
markers makes such approaches straightforward, or at
least feasible (Doerge, 2002).
Perhaps the most advanced ‘‘omics’’ is functional gen-
omics or transcriptomics, the study of all mRNA transcripts
expressed by a certain cell. Microarrays or DNA chips that
can probe complete transcriptomes come in two varieties:
printed complementary DNA (cDNA) and synthetic
oligonucleotide. The first, originated by P. Brown at Stan-
ford (Schena et al, 1995), are often home-made, inexpen-
sive, and two-color, i.e., treated and control samples can be
hybridized and compared on the same chip. They are easy
to customize for a specific application. Synthetic oligonuc-
leotide microarrays, e.g., those produced photo-litographi-
cally by Affymetrix (Santa Clara, California), are commercially
available, at a price, but because each gene is probed with
multiple oligonucleotides, they tend to be more reliable and
require less redundancy. They are one-color, i.e., they probe
only one sample per array, but the newer ones contain all
the known human genes, and the future ones will be able to
identify the splicing variants as well.
To address the differences in technique, data quality,
etc., the microarray community has promulgated a set of
guidelines known as ‘‘MIAME’’ rules (minimal information
about a microarray experiment). The MIAME rules have been
adopted by a growing number of journals, and compliance is
a requirement of acceptance for publication. Currently, the
functional annotation of many genes is inadequate; this is-
sue is being addressed by concerted international efforts at
several genomics centers (Birney et al, 2004).
Transcriptomics addresses changes in gene expression;
however, the abundance of mRNA does not necessarily
correlate with the abundance of protein. Furthermore, the
function of a protein is often modified post-transcriptionally.
Enter proteomics. First defined as the study of the complete
protein content of a given cell at given conditions, pro-
teomics studies usually involves separating the proteins by
physical methods, e.g., 2-D gels, and identifying them, e.g.,
by mass spectroscopy (de Hoog and Mann, 2004). Data
banks of protein sequences are necessary for identification,
and additional experiments can indicate post-transcription-
al modifications, such as phosphorylation, glycosylation,
ubiquitination, or methylation. Proteomics studies can,
therefore, not only determine the levels of expression of
most proteins in a cell but also their modification and, con-
sequently, activity.
Proteomics can also be used to study protein–protein
interactions, e.g., the full complement of the proteins in an
organelle, or the interacting proteins in a signaling pathway.
Two-hybrid, co-precipitation, cross-linking, and similar ap-
proaches have been used to isolate the proteins of interest.
The three common components of such studies are a
Abbreviation: UV, ultraviolet
1The following omes and omics terms found their way in the
literature: bibliome, biome, cardiogenomics, cellome, cytome/
omics, epigenomics, expressome, fluxome, foldome, immunomics,
integromics, interactome, ligandomics, localizome, metabolome/
omics, methylome, microbiome, morphome, nucleome, operomics,
ORFeome, peptidome/omics, pharmacomethylomics, phenome,
phenomics, phosphatome, physiogenomics, pseudogenome, re-
gulome, RNomics, secretome, separomics, signalome, systeome,
transgenomics, translatome, transportome, vaccinome, variomics.
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comprehensive approach, reliance on data banks, and
computed-based analysis.
Skin is a very accessible target; consequently, skin cells
were among the earliest topics of microarray studies. Iyer
et al (1998) analyzed the response of dermal fibroblasts to
the addition of serum, a paradigm for cell cycle studies. As
expected, the authors found cell cycle regulators to be
induced by serum; unexpectedly, they also found that fi-
broblasts initiated the expression of the wound-healing
response proteins. Only a transcriptome analysis could
provide the global overview that made it possible to identify
the wound repair proteins induced in fibroblasts in response
to serum. A skin-specific cDNA array, named DermArray
(IntegriDerm, Birmingham, Alabama) and containing  4000
genes, has recently become commercially available (Curto
et al, 2002).
Omics have been used to analyze the molecular effects
of ultraviolet (UV) light in skin (Li et al, 2001; Murakami et al,
2001; Sesto et al, 2002; Takao et al, 2002; Howell et al,
2004). Given the differences in time-frame, geography, and
experimental details, the results from different laboratories
are amazingly congruent. The UV-treated keratinocytes
both protect themselves from the damage, as well as pro-
tect the underlying organism. Some of the responses had
been expected, whereas others were novel and provided
fresh views into the protective role of epidermis. Interest-
ingly, starting from congruent, basically identical data, dif-
ferent researchers emphasized different aspects of the
results. Like the parable of the blind men and the elephant,
our group focused on the metabolic and differentiation ef-
fects; Sesto et al were interested in DNA repair, Murakami
et al in oncogenes, Howell et al in angiogenesis, etc. The large
amounts of data, while providing new knowledge, can allow
researchers to pursue individual interests and inclinations.
In this issue, Hensbergen et al adopt the proteomic ap-
proach to analyze the effects of UV on epidermis. The au-
thors irradiated skin equivalents with a mix of UVA and UVB,
using a solar stimulator. After 16 h, they isolated the epi-
dermal proteins, resolved them on 2-D gels, and compared
the irradiated with the control samples. Having performed
the experiments on four individuals in duplicate, the authors
could identify the UV-caused changes in protein levels with
great confidence. Many spots changed in response to UV.
Importantly, heat shock protein-27 and MnSOD, two pro-
teins known to be induced by UV, were found at higher
levels in the irradiated samples, which validated the meth-
odology.
Hensbergen et al focused on an interesting set of two
protein spots that are diminished by UV. They identified
these as cofilin-1 and destrin, two closely related, small,
actin-depolymerizing factors. Using an ingenious gallium
affinity column that binds phospho-peptides, they showed
that the disappearing spots belong to the phosphorylated,
inactive forms of cofilin and destrin. The total levels of the
proteins remained the same, which means that the proteins
are dephosphorylated, not degraded. This means that UV
causes a specific dephosphorylation and consequent acti-
vation of cofilin and destrin. Significantly, Hensbergen et al
go on to show that the same dephosphorylation of cofilin
and destrin occurs in native UV-irradiated human skin as
well, not just in skin equivalents.
Active cofilin and destrin depolymerize and sever actin
filaments, disrupting stress fibers and reorganizing micro-
filaments, which enhances cell motility and perhaps inhibits
proliferation. The results of Hensbergen et al directly identify
the molecular effects of UV irradiation that cause cytoskel-
etal changes in keratinocytes, complementing those
predicted through transcriptomics (Li et al, 2001). The
concerted efforts of proteomics and transcriptomics thus
synergistically increase our understanding of the molecular
effects of UV on skin.
There have not been many studies in which both the
transcriptome and the proteome have been defined in the
same system. Skin is again at the cutting edge. Because of
its importance in dermatology, the effects of UV were the
first to receive intensive attention. Although there are some
differences in the experimental models, skin equivalents
versus monolayer cultures, UVAþUVB versus UVB alone,
the results are, again, quite congruent. The transcriptional
changes gave guidance to the proteomic approach and
validity to the results. Proteomics confirmed that changes in
the mRNA levels in general, correspond to changes in the
protein levels. Proteomics took a substantial step forward,
however, by demonstrating the importance of post-transla-
tional protein modification in responses to UV, namely pro-
tein dephosphorylation.
It is important to appreciate that the changes in post-
transcriptional modification seen in the proteomic experi-
ments of Hensbergen et al could not be detected using
transcriptomics. As pointed out by the authors, transcript-
omics only identifies changes in mRNA levels, which do not
always reflect the quantity of a protein present in the cell,
and certainly cannot address protein modification. Theirs is
a classic proteomics study: it starts with a broad picture, a
global overview of all proteomic changes caused by UV light
in epidermis. Importantly, it uses a large number of repli-
cates, which allows the authors to draw reliable conclusions.
Then, the study selects the most reliably demonstrated
changes and confirms the facts known from the literature.
Finally, it focuses on a specific detail, explores it in depth,
and provides new insights into an important process.
Obviously, this is just the beginning of proteomics in
dermatology research. Even in Hensbergen et al, there are
many more differentially expressed spots in Figure 1 that
have not yet been analyzed by the authors; these will be
characterized eventually. Other groups will join in and soon
we will require a dedicated and practical cutaneous omics
database. Perhaps, SID will lead the way in establishing it.
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